| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, N-Methyl-D-Aspartate | 69 | 2024 | 893 | 10.380 |
Why?
|
| Racemases and Epimerases | 32 | 2021 | 112 | 9.260 |
Why?
|
| Serine | 27 | 2021 | 829 | 5.800 |
Why?
|
| Schizophrenia | 69 | 2024 | 6914 | 5.090 |
Why?
|
| Glutamic Acid | 27 | 2024 | 1166 | 3.620 |
Why?
|
| Dipeptides | 21 | 2012 | 410 | 2.180 |
Why?
|
| Glutamate Carboxypeptidase II | 18 | 2012 | 81 | 1.870 |
Why?
|
| Glutamates | 11 | 2006 | 391 | 1.740 |
Why?
|
| Neurons | 35 | 2022 | 9411 | 1.680 |
Why?
|
| Astrocytes | 9 | 2019 | 1333 | 1.670 |
Why?
|
| Glycine | 20 | 2019 | 663 | 1.660 |
Why?
|
| Hippocampus | 23 | 2019 | 3727 | 1.620 |
Why?
|
| Receptors, Glutamate | 12 | 2020 | 229 | 1.520 |
Why?
|
| Dendrites | 6 | 2020 | 475 | 1.400 |
Why?
|
| Synapses | 12 | 2024 | 1748 | 1.400 |
Why?
|
| Antipsychotic Agents | 20 | 2017 | 3060 | 1.310 |
Why?
|
| Neuronal Plasticity | 13 | 2020 | 1428 | 1.280 |
Why?
|
| Prefrontal Cortex | 11 | 2021 | 2210 | 1.120 |
Why?
|
| Carboxypeptidases | 8 | 2004 | 155 | 1.090 |
Why?
|
| Pyramidal Cells | 8 | 2020 | 369 | 1.080 |
Why?
|
| Excitatory Amino Acid Agonists | 5 | 2020 | 143 | 1.050 |
Why?
|
| Antigens, Surface | 9 | 2009 | 1616 | 1.040 |
Why?
|
| Mice, Knockout | 33 | 2021 | 14381 | 1.010 |
Why?
|
| Kainic Acid | 9 | 2005 | 199 | 0.980 |
Why?
|
| Schizophrenic Psychology | 9 | 2017 | 1646 | 0.950 |
Why?
|
| Dendritic Spines | 6 | 2017 | 243 | 0.940 |
Why?
|
| Synaptic Transmission | 16 | 2021 | 1169 | 0.940 |
Why?
|
| Behavior, Animal | 7 | 2014 | 1858 | 0.930 |
Why?
|
| Conditioning, Classical | 2 | 2017 | 363 | 0.930 |
Why?
|
| Brain | 36 | 2022 | 26863 | 0.920 |
Why?
|
| Prosencephalon | 4 | 2014 | 304 | 0.920 |
Why?
|
| Dizocilpine Maleate | 7 | 2020 | 172 | 0.910 |
Why?
|
| Animals | 121 | 2024 | 167838 | 0.880 |
Why?
|
| Cocaine | 4 | 2020 | 961 | 0.880 |
Why?
|
| Cognition Disorders | 11 | 2016 | 3972 | 0.850 |
Why?
|
| Excitatory Amino Acid Antagonists | 11 | 2015 | 447 | 0.840 |
Why?
|
| Entorhinal Cortex | 2 | 2019 | 277 | 0.830 |
Why?
|
| Interneurons | 6 | 2022 | 589 | 0.820 |
Why?
|
| Neurotransmitter Agents | 8 | 2010 | 661 | 0.790 |
Why?
|
| D-Amino-Acid Oxidase | 2 | 2020 | 25 | 0.770 |
Why?
|
| Cocaine-Related Disorders | 2 | 2015 | 460 | 0.740 |
Why?
|
| Nerve Tissue Proteins | 9 | 2021 | 4409 | 0.730 |
Why?
|
| Motor Activity | 7 | 2015 | 2687 | 0.720 |
Why?
|
| gamma-Aminobutyric Acid | 9 | 2020 | 1132 | 0.720 |
Why?
|
| Neurosciences | 3 | 2016 | 353 | 0.710 |
Why?
|
| Clozapine | 8 | 2014 | 506 | 0.710 |
Why?
|
| Periodicals as Topic | 8 | 2013 | 1469 | 0.710 |
Why?
|
| Neuropeptides | 10 | 1998 | 941 | 0.700 |
Why?
|
| Dopamine | 8 | 2024 | 1583 | 0.660 |
Why?
|
| Glycine Plasma Membrane Transport Proteins | 8 | 2016 | 21 | 0.640 |
Why?
|
| Cycloserine | 6 | 2005 | 118 | 0.630 |
Why?
|
| Mice | 50 | 2024 | 81138 | 0.620 |
Why?
|
| Haloperidol | 4 | 2014 | 389 | 0.610 |
Why?
|
| Fear | 2 | 2017 | 1461 | 0.610 |
Why?
|
| Allosteric Regulation | 4 | 2016 | 426 | 0.600 |
Why?
|
| Self Stimulation | 1 | 2017 | 47 | 0.600 |
Why?
|
| Somatosensory Cortex | 2 | 2012 | 510 | 0.600 |
Why?
|
| Nucleus Accumbens | 2 | 2017 | 365 | 0.580 |
Why?
|
| Gene Expression Regulation | 11 | 2021 | 11908 | 0.570 |
Why?
|
| Dipeptidases | 5 | 1997 | 38 | 0.560 |
Why?
|
| Cerebral Cortex | 11 | 2020 | 5754 | 0.540 |
Why?
|
| Dopamine Uptake Inhibitors | 2 | 2017 | 297 | 0.530 |
Why?
|
| Aspartic Acid | 6 | 2006 | 576 | 0.530 |
Why?
|
| Callithrix | 1 | 2016 | 93 | 0.520 |
Why?
|
| Disease Models, Animal | 19 | 2021 | 18110 | 0.510 |
Why?
|
| Psychopharmacology | 2 | 2012 | 148 | 0.510 |
Why?
|
| Reversal Learning | 1 | 2016 | 57 | 0.510 |
Why?
|
| Names | 5 | 2012 | 52 | 0.510 |
Why?
|
| Phencyclidine | 5 | 2010 | 60 | 0.510 |
Why?
|
| Neurotoxins | 7 | 2010 | 240 | 0.510 |
Why?
|
| Bipolar Disorder | 12 | 2018 | 5076 | 0.510 |
Why?
|
| Rats | 35 | 2019 | 23694 | 0.500 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2017 | 490 | 0.500 |
Why?
|
| Post-Synaptic Density | 2 | 2012 | 11 | 0.490 |
Why?
|
| Cholinesterase Inhibitors | 3 | 2008 | 238 | 0.480 |
Why?
|
| Amphetamines | 2 | 2013 | 143 | 0.480 |
Why?
|
| Cerebellum | 9 | 2018 | 1495 | 0.480 |
Why?
|
| Oxazoles | 1 | 2016 | 198 | 0.470 |
Why?
|
| Galantamine | 2 | 2007 | 33 | 0.470 |
Why?
|
| Amphetamine | 3 | 2012 | 224 | 0.470 |
Why?
|
| Discrimination Learning | 1 | 2016 | 278 | 0.460 |
Why?
|
| Psychiatry | 5 | 2013 | 1683 | 0.450 |
Why?
|
| Excitatory Postsynaptic Potentials | 4 | 2013 | 369 | 0.450 |
Why?
|
| Receptors, Dopamine | 4 | 2021 | 292 | 0.450 |
Why?
|
| Parvalbumins | 2 | 2017 | 258 | 0.440 |
Why?
|
| Extinction, Psychological | 2 | 2017 | 371 | 0.440 |
Why?
|
| Nitroprusside | 1 | 2013 | 273 | 0.430 |
Why?
|
| Signal Transduction | 15 | 2019 | 23362 | 0.430 |
Why?
|
| Mice, Inbred C57BL | 17 | 2021 | 21981 | 0.430 |
Why?
|
| Phencyclidine Abuse | 1 | 2012 | 8 | 0.430 |
Why?
|
| Maze Learning | 2 | 2012 | 477 | 0.430 |
Why?
|
| Cytoskeletal Proteins | 2 | 2017 | 1344 | 0.420 |
Why?
|
| Serotonin Receptor Agonists | 1 | 2013 | 151 | 0.420 |
Why?
|
| Superoxide Dismutase | 5 | 1998 | 593 | 0.420 |
Why?
|
| Receptors, Amino Acid | 1 | 2012 | 30 | 0.410 |
Why?
|
| Neuroglia | 4 | 2005 | 944 | 0.410 |
Why?
|
| Alcoholism | 4 | 2013 | 1952 | 0.410 |
Why?
|
| Corpus Striatum | 6 | 2020 | 1232 | 0.410 |
Why?
|
| Research | 1 | 2020 | 1972 | 0.400 |
Why?
|
| Anesthetics, Dissociative | 1 | 2012 | 79 | 0.400 |
Why?
|
| Long-Term Potentiation | 4 | 2016 | 293 | 0.400 |
Why?
|
| Amygdala | 2 | 2017 | 1350 | 0.390 |
Why?
|
| Psychoses, Substance-Induced | 1 | 2012 | 98 | 0.390 |
Why?
|
| Alzheimer Disease | 9 | 2019 | 8540 | 0.390 |
Why?
|
| Magnetic Resonance Spectroscopy | 4 | 2016 | 3762 | 0.390 |
Why?
|
| Homocysteine | 2 | 2005 | 640 | 0.390 |
Why?
|
| Folic Acid Deficiency | 1 | 2012 | 115 | 0.390 |
Why?
|
| Psychotropic Drugs | 4 | 2019 | 882 | 0.370 |
Why?
|
| Auditory Cortex | 1 | 2015 | 363 | 0.370 |
Why?
|
| Receptors, Nicotinic | 2 | 2007 | 494 | 0.370 |
Why?
|
| Folic Acid | 4 | 2005 | 1303 | 0.360 |
Why?
|
| Brain Chemistry | 8 | 2017 | 959 | 0.360 |
Why?
|
| Humans | 122 | 2024 | 759255 | 0.340 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2016 | 2448 | 0.340 |
Why?
|
| Amino Acid Transport Systems, Neutral | 3 | 2005 | 39 | 0.330 |
Why?
|
| Glycine Dehydrogenase (Decarboxylating) | 2 | 2019 | 15 | 0.320 |
Why?
|
| Substance-Related Disorders | 3 | 2017 | 4358 | 0.310 |
Why?
|
| Brain Diseases | 1 | 2017 | 1540 | 0.310 |
Why?
|
| Excitatory Amino Acids | 2 | 2005 | 17 | 0.310 |
Why?
|
| Motion Perception | 1 | 2012 | 372 | 0.310 |
Why?
|
| Male | 71 | 2021 | 358719 | 0.310 |
Why?
|
| Publishing | 5 | 2012 | 837 | 0.310 |
Why?
|
| Behavior, Addictive | 1 | 2013 | 462 | 0.300 |
Why?
|
| Nootropic Agents | 2 | 2007 | 157 | 0.300 |
Why?
|
| Neural Inhibition | 2 | 2010 | 589 | 0.290 |
Why?
|
| Receptors, AMPA | 3 | 2020 | 323 | 0.290 |
Why?
|
| Allosteric Site | 2 | 2012 | 104 | 0.290 |
Why?
|
| Hallucinogens | 1 | 2010 | 194 | 0.280 |
Why?
|
| Paired-Associate Learning | 1 | 2006 | 53 | 0.280 |
Why?
|
| Lithium | 2 | 2017 | 596 | 0.280 |
Why?
|
| Mood Disorders | 2 | 2003 | 1123 | 0.270 |
Why?
|
| Brain-Derived Neurotrophic Factor | 3 | 2017 | 597 | 0.270 |
Why?
|
| Psychiatric Status Rating Scales | 10 | 2012 | 6016 | 0.270 |
Why?
|
| Quinoxalines | 4 | 2020 | 288 | 0.270 |
Why?
|
| Rats, Sprague-Dawley | 16 | 2015 | 8157 | 0.260 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 1 | 2007 | 187 | 0.260 |
Why?
|
| Rett Syndrome | 1 | 2007 | 164 | 0.260 |
Why?
|
| Central Nervous System Stimulants | 2 | 2012 | 1169 | 0.250 |
Why?
|
| Gene Expression Regulation, Enzymologic | 3 | 2010 | 1173 | 0.250 |
Why?
|
| Amino Acids | 5 | 2019 | 1715 | 0.250 |
Why?
|
| RNA, Messenger | 9 | 2015 | 12774 | 0.250 |
Why?
|
| Nerve Degeneration | 5 | 1997 | 748 | 0.240 |
Why?
|
| Dairying | 1 | 2024 | 12 | 0.240 |
Why?
|
| Mice, Transgenic | 9 | 2014 | 9528 | 0.240 |
Why?
|
| History, 20th Century | 3 | 2020 | 2777 | 0.240 |
Why?
|
| Induced Pluripotent Stem Cells | 5 | 2020 | 1845 | 0.240 |
Why?
|
| Pyridines | 1 | 2016 | 2875 | 0.230 |
Why?
|
| Tryptophan | 1 | 2005 | 480 | 0.220 |
Why?
|
| Editorial Policies | 2 | 2012 | 457 | 0.220 |
Why?
|
| Influenza A Virus, H5N1 Subtype | 1 | 2024 | 113 | 0.220 |
Why?
|
| Receptor, trkB | 2 | 2015 | 125 | 0.220 |
Why?
|
| Antimanic Agents | 2 | 2006 | 520 | 0.220 |
Why?
|
| Intracellular Fluid | 1 | 2003 | 201 | 0.210 |
Why?
|
| Calcium Channels, L-Type | 2 | 2002 | 239 | 0.210 |
Why?
|
| Atrophy | 3 | 2017 | 1625 | 0.210 |
Why?
|
| Cells, Cultured | 16 | 2018 | 18968 | 0.210 |
Why?
|
| Heterozygote | 1 | 2009 | 2796 | 0.210 |
Why?
|
| Microglia | 3 | 2020 | 1347 | 0.200 |
Why?
|
| Gene Expression | 6 | 2020 | 7593 | 0.200 |
Why?
|
| Autistic Disorder | 1 | 2012 | 1213 | 0.200 |
Why?
|
| Oxidative Stress | 3 | 1998 | 3106 | 0.200 |
Why?
|
| Huntington Disease | 3 | 1997 | 1140 | 0.200 |
Why?
|
| Glutamate Decarboxylase | 3 | 2010 | 239 | 0.200 |
Why?
|
| Asperger Syndrome | 1 | 2002 | 56 | 0.200 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2024 | 249 | 0.200 |
Why?
|
| Glutamine | 2 | 2016 | 576 | 0.200 |
Why?
|
| Patch-Clamp Techniques | 5 | 2008 | 932 | 0.200 |
Why?
|
| Psychotic Disorders | 2 | 2019 | 3170 | 0.190 |
Why?
|
| Mental Recall | 2 | 2010 | 1201 | 0.190 |
Why?
|
| Dose-Response Relationship, Drug | 9 | 2013 | 10827 | 0.190 |
Why?
|
| MicroRNAs | 3 | 2017 | 3797 | 0.190 |
Why?
|
| Transcriptional Activation | 1 | 2007 | 1756 | 0.190 |
Why?
|
| Chromatography, High Pressure Liquid | 4 | 2013 | 1547 | 0.190 |
Why?
|
| Antidepressive Agents | 3 | 2006 | 2888 | 0.190 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2013 | 2486 | 0.190 |
Why?
|
| Rotarod Performance Test | 2 | 2012 | 63 | 0.190 |
Why?
|
| History, 21st Century | 2 | 2020 | 1576 | 0.180 |
Why?
|
| Societies, Medical | 1 | 2013 | 3890 | 0.180 |
Why?
|
| Microdialysis | 2 | 2017 | 160 | 0.180 |
Why?
|
| Reactive Oxygen Species | 2 | 2002 | 2135 | 0.180 |
Why?
|
| Fetal Diseases | 1 | 2005 | 910 | 0.170 |
Why?
|
| Glycine Agents | 1 | 2019 | 16 | 0.170 |
Why?
|
| Glycogen Synthase Kinase 3 | 2 | 2015 | 409 | 0.170 |
Why?
|
| Rats, Transgenic | 1 | 2019 | 69 | 0.170 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2017 | 4525 | 0.170 |
Why?
|
| Cues | 2 | 2016 | 867 | 0.170 |
Why?
|
| Anorexia Nervosa | 1 | 2008 | 1357 | 0.160 |
Why?
|
| Drug Therapy, Combination | 9 | 2019 | 6496 | 0.160 |
Why?
|
| Immunohistochemistry | 6 | 2017 | 11058 | 0.160 |
Why?
|
| Phenotype | 2 | 2009 | 16532 | 0.160 |
Why?
|
| Medicine in Literature | 1 | 1999 | 31 | 0.160 |
Why?
|
| Homozygote | 1 | 2003 | 1786 | 0.160 |
Why?
|
| Cell Survival | 5 | 2002 | 5796 | 0.160 |
Why?
|
| Creutzfeldt-Jakob Syndrome | 1 | 1999 | 91 | 0.160 |
Why?
|
| Conditioning, Operant | 3 | 2015 | 308 | 0.160 |
Why?
|
| Smoking | 2 | 2013 | 9066 | 0.150 |
Why?
|
| Lipid Peroxides | 2 | 1998 | 74 | 0.150 |
Why?
|
| Affective Disorders, Psychotic | 1 | 2019 | 186 | 0.150 |
Why?
|
| Complement C3a | 1 | 2018 | 66 | 0.150 |
Why?
|
| Female | 41 | 2021 | 390240 | 0.150 |
Why?
|
| Histamine H1 Antagonists | 1 | 1998 | 100 | 0.150 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2007 | 1889 | 0.150 |
Why?
|
| Dyskinesia, Drug-Induced | 1 | 1998 | 165 | 0.150 |
Why?
|
| Embryo, Mammalian | 1 | 2003 | 1666 | 0.150 |
Why?
|
| Physicians | 1 | 2016 | 4586 | 0.150 |
Why?
|
| Models, Biological | 5 | 2017 | 9466 | 0.150 |
Why?
|
| Receptors, Metabotropic Glutamate | 2 | 2009 | 196 | 0.150 |
Why?
|
| Needs Assessment | 1 | 2003 | 1137 | 0.150 |
Why?
|
| Mutation | 3 | 2012 | 29877 | 0.150 |
Why?
|
| Mutagenesis, Site-Directed | 3 | 2007 | 1694 | 0.150 |
Why?
|
| Nerve Tissue | 1 | 1997 | 78 | 0.150 |
Why?
|
| Physicians, Family | 1 | 1999 | 350 | 0.150 |
Why?
|
| Down-Regulation | 3 | 2017 | 2920 | 0.140 |
Why?
|
| Central Nervous System Diseases | 1 | 2002 | 521 | 0.140 |
Why?
|
| Trans-Activators | 1 | 2007 | 2860 | 0.140 |
Why?
|
| Ethanol | 3 | 1998 | 1314 | 0.140 |
Why?
|
| Spouses | 1 | 1999 | 279 | 0.140 |
Why?
|
| Ion Channel Gating | 1 | 1999 | 436 | 0.140 |
Why?
|
| Drug Administration Schedule | 6 | 2003 | 4898 | 0.140 |
Why?
|
| Receptor, EphB3 | 1 | 2016 | 11 | 0.140 |
Why?
|
| Analysis of Variance | 4 | 2015 | 6242 | 0.140 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2021 | 1655 | 0.140 |
Why?
|
| GABA Antagonists | 2 | 2008 | 120 | 0.140 |
Why?
|
| Nifedipine | 3 | 2002 | 221 | 0.130 |
Why?
|
| Spinal Cord | 3 | 1999 | 1815 | 0.130 |
Why?
|
| Occupational Diseases | 1 | 2024 | 1484 | 0.130 |
Why?
|
| Blotting, Northern | 4 | 2003 | 1544 | 0.130 |
Why?
|
| Sensory Gating | 2 | 2021 | 47 | 0.130 |
Why?
|
| Promoter Regions, Genetic | 1 | 2007 | 5789 | 0.130 |
Why?
|
| Biogenic Amines | 1 | 1995 | 53 | 0.130 |
Why?
|
| Space Perception | 2 | 2009 | 464 | 0.130 |
Why?
|
| Culture Media | 1 | 2018 | 899 | 0.130 |
Why?
|
| Circadian Rhythm | 1 | 2007 | 2567 | 0.130 |
Why?
|
| Calcium Channels | 1 | 1999 | 619 | 0.130 |
Why?
|
| Transcription, Genetic | 2 | 2007 | 7595 | 0.130 |
Why?
|
| Ketamine | 2 | 2012 | 514 | 0.120 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 2 | 2015 | 173 | 0.120 |
Why?
|
| Nervous System Diseases | 2 | 1997 | 1645 | 0.120 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2016 | 36160 | 0.120 |
Why?
|
| Pyruvates | 1 | 2014 | 84 | 0.120 |
Why?
|
| Conflict of Interest | 1 | 1999 | 549 | 0.120 |
Why?
|
| Photic Stimulation | 4 | 2020 | 1967 | 0.120 |
Why?
|
| Neuropsychology | 1 | 1995 | 107 | 0.120 |
Why?
|
| Retinal Ganglion Cells | 2 | 2011 | 805 | 0.120 |
Why?
|
| Mothers | 1 | 2005 | 2181 | 0.120 |
Why?
|
| Silver Staining | 2 | 2012 | 63 | 0.120 |
Why?
|
| Gastric Inhibitory Polypeptide | 1 | 2014 | 66 | 0.120 |
Why?
|
| Acoustic Stimulation | 2 | 2009 | 1232 | 0.120 |
Why?
|
| Blotting, Western | 3 | 2010 | 5039 | 0.120 |
Why?
|
| Central Nervous System | 1 | 2002 | 1334 | 0.120 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2019 | 529 | 0.120 |
Why?
|
| Apoptosis | 5 | 1999 | 9492 | 0.120 |
Why?
|
| Oligodendroglia | 1 | 1998 | 535 | 0.120 |
Why?
|
| Butylated Hydroxytoluene | 1 | 1993 | 8 | 0.120 |
Why?
|
| Cadherins | 1 | 2019 | 898 | 0.120 |
Why?
|
| Nerve Net | 2 | 2021 | 2253 | 0.120 |
Why?
|
| Schwann Cells | 1 | 1995 | 196 | 0.120 |
Why?
|
| Mitochondria | 4 | 2020 | 3600 | 0.110 |
Why?
|
| Hydroxyindoleacetic Acid | 1 | 2013 | 93 | 0.110 |
Why?
|
| Receptors, Cholinergic | 2 | 2010 | 244 | 0.110 |
Why?
|
| Enteroendocrine Cells | 1 | 2014 | 77 | 0.110 |
Why?
|
| Peripheral Nervous System | 1 | 1995 | 151 | 0.110 |
Why?
|
| Calcium Channel Blockers | 4 | 2002 | 691 | 0.110 |
Why?
|
| Choline | 1 | 1995 | 513 | 0.110 |
Why?
|
| N-Methylaspartate | 5 | 2015 | 231 | 0.110 |
Why?
|
| Cytoplasm | 1 | 1998 | 1521 | 0.110 |
Why?
|
| Chromans | 1 | 1993 | 117 | 0.110 |
Why?
|
| Cognition | 4 | 2012 | 6940 | 0.110 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 1998 | 623 | 0.110 |
Why?
|
| Protein Isoforms | 1 | 2018 | 1695 | 0.110 |
Why?
|
| Stereoisomerism | 1 | 2014 | 618 | 0.110 |
Why?
|
| Age Determination by Skeleton | 1 | 2013 | 126 | 0.110 |
Why?
|
| Kinetics | 6 | 2005 | 6380 | 0.110 |
Why?
|
| Social Behavior | 3 | 2021 | 1130 | 0.110 |
Why?
|
| Extracellular Space | 1 | 2015 | 565 | 0.110 |
Why?
|
| Dog Diseases | 1 | 1993 | 140 | 0.110 |
Why?
|
| Influenza, Human | 1 | 2024 | 1533 | 0.110 |
Why?
|
| L-Serine Dehydratase | 1 | 2012 | 7 | 0.110 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2015 | 2867 | 0.110 |
Why?
|
| Base Sequence | 5 | 2007 | 12450 | 0.110 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2000 | 1919 | 0.100 |
Why?
|
| Head Movements | 1 | 2013 | 152 | 0.100 |
Why?
|
| Models, Neurological | 3 | 2008 | 1757 | 0.100 |
Why?
|
| Double-Blind Method | 7 | 2019 | 12386 | 0.100 |
Why?
|
| Coloring Agents | 2 | 2012 | 561 | 0.100 |
Why?
|
| Memory Disorders | 2 | 2010 | 1194 | 0.100 |
Why?
|
| Neuromuscular Junction | 1 | 1995 | 406 | 0.100 |
Why?
|
| Hyperkinesis | 1 | 2012 | 89 | 0.100 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2014 | 366 | 0.100 |
Why?
|
| Taurine | 2 | 2015 | 93 | 0.100 |
Why?
|
| Neurology | 1 | 2000 | 775 | 0.100 |
Why?
|
| Nerve Regeneration | 1 | 1997 | 790 | 0.100 |
Why?
|
| Granulocytes | 1 | 1993 | 551 | 0.100 |
Why?
|
| Sex Characteristics | 2 | 2020 | 2627 | 0.100 |
Why?
|
| Michigan | 2 | 2024 | 340 | 0.090 |
Why?
|
| Vision, Ocular | 2 | 2011 | 453 | 0.090 |
Why?
|
| Viral Nonstructural Proteins | 1 | 2012 | 223 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2013 | 587 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2011 | 4573 | 0.090 |
Why?
|
| Meta-Analysis as Topic | 1 | 2016 | 1375 | 0.090 |
Why?
|
| Exons | 2 | 2009 | 2389 | 0.090 |
Why?
|
| Cell Fractionation | 1 | 2011 | 251 | 0.090 |
Why?
|
| Intelligence Tests | 1 | 2012 | 498 | 0.090 |
Why?
|
| Brain Injuries | 3 | 2017 | 2043 | 0.090 |
Why?
|
| Drug Delivery Systems | 1 | 2002 | 2218 | 0.090 |
Why?
|
| Behavioral Symptoms | 1 | 2012 | 185 | 0.090 |
Why?
|
| Lipopolysaccharides | 1 | 1998 | 2213 | 0.090 |
Why?
|
| Muscular Atrophy, Spinal | 1 | 1993 | 258 | 0.090 |
Why?
|
| Gene Knockdown Techniques | 1 | 2015 | 1619 | 0.090 |
Why?
|
| Haploinsufficiency | 1 | 2012 | 329 | 0.090 |
Why?
|
| Dopamine Antagonists | 2 | 2003 | 288 | 0.090 |
Why?
|
| Serotonin | 2 | 2013 | 1034 | 0.090 |
Why?
|
| Comorbidity | 3 | 2019 | 10547 | 0.090 |
Why?
|
| Microfilament Proteins | 1 | 2015 | 1134 | 0.080 |
Why?
|
| Placebos | 3 | 1999 | 1672 | 0.080 |
Why?
|
| Cytoprotection | 1 | 2010 | 200 | 0.080 |
Why?
|
| Nitric Oxide | 3 | 2010 | 2142 | 0.080 |
Why?
|
| Phosphinic Acids | 1 | 2008 | 17 | 0.080 |
Why?
|
| 2-Amino-5-phosphonovalerate | 2 | 2007 | 58 | 0.080 |
Why?
|
| Aging | 3 | 2015 | 8634 | 0.080 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2017 | 1972 | 0.080 |
Why?
|
| Rats, Long-Evans | 2 | 2007 | 373 | 0.080 |
Why?
|
| Dementia | 1 | 2003 | 2634 | 0.080 |
Why?
|
| Hepatitis C | 1 | 2019 | 1578 | 0.080 |
Why?
|
| Chelating Agents | 2 | 2002 | 384 | 0.080 |
Why?
|
| Tissue Distribution | 3 | 1998 | 2262 | 0.080 |
Why?
|
| Cloning, Molecular | 3 | 1998 | 4171 | 0.080 |
Why?
|
| Electron Transport | 2 | 2002 | 206 | 0.080 |
Why?
|
| Chlorpyrifos | 1 | 2008 | 19 | 0.080 |
Why?
|
| Cell Death | 3 | 2002 | 1669 | 0.080 |
Why?
|
| Receptors, GABA | 1 | 2010 | 305 | 0.070 |
Why?
|
| Antigens, Neoplasm | 1 | 1996 | 1997 | 0.070 |
Why?
|
| Brain Mapping | 2 | 2006 | 6559 | 0.070 |
Why?
|
| Benzylamines | 1 | 2008 | 233 | 0.070 |
Why?
|
| Biotin | 1 | 2008 | 253 | 0.070 |
Why?
|
| Protein Subunits | 1 | 2011 | 943 | 0.070 |
Why?
|
| Adult | 20 | 2020 | 219390 | 0.070 |
Why?
|
| Chemokine CXCL6 | 1 | 2007 | 14 | 0.070 |
Why?
|
| Molecular Sequence Data | 4 | 2007 | 17629 | 0.070 |
Why?
|
| Middle Aged | 17 | 2020 | 219653 | 0.070 |
Why?
|
| Perforant Pathway | 1 | 2006 | 24 | 0.070 |
Why?
|
| CLOCK Proteins | 1 | 2007 | 86 | 0.070 |
Why?
|
| Alcohol Deterrents | 1 | 2006 | 45 | 0.070 |
Why?
|
| Osteogenesis | 1 | 2013 | 1268 | 0.070 |
Why?
|
| Sodium | 2 | 2004 | 1601 | 0.070 |
Why?
|
| Insecticides | 1 | 2008 | 191 | 0.070 |
Why?
|
| Reference Values | 3 | 1998 | 4918 | 0.070 |
Why?
|
| Physician-Patient Relations | 1 | 1999 | 3236 | 0.070 |
Why?
|
| DNA, Complementary | 3 | 2004 | 1993 | 0.070 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 1995 | 1488 | 0.070 |
Why?
|
| Membrane Proteins | 2 | 2015 | 7851 | 0.070 |
Why?
|
| Electric Stimulation | 3 | 2007 | 1736 | 0.070 |
Why?
|
| Motivation | 1 | 2016 | 1991 | 0.070 |
Why?
|
| 5' Untranslated Regions | 1 | 2007 | 256 | 0.070 |
Why?
|
| Ikaros Transcription Factor | 1 | 2007 | 231 | 0.060 |
Why?
|
| Organophosphorus Compounds | 1 | 2007 | 202 | 0.060 |
Why?
|
| Temporal Lobe | 3 | 2018 | 1687 | 0.060 |
Why?
|
| Luciferases | 1 | 2007 | 717 | 0.060 |
Why?
|
| Neurobiology | 1 | 2006 | 137 | 0.060 |
Why?
|
| Lidocaine | 1 | 2008 | 538 | 0.060 |
Why?
|
| Limbic System | 2 | 2001 | 419 | 0.060 |
Why?
|
| Genome-Wide Association Study | 3 | 2022 | 12580 | 0.060 |
Why?
|
| Microscopy, Electron | 2 | 2002 | 2558 | 0.060 |
Why?
|
| Memory | 2 | 2009 | 2179 | 0.060 |
Why?
|
| Kynurenine | 1 | 2005 | 140 | 0.060 |
Why?
|
| Chemokines, CXC | 1 | 2007 | 421 | 0.060 |
Why?
|
| Homocystinuria | 1 | 2005 | 64 | 0.060 |
Why?
|
| Knee Joint | 1 | 2013 | 1660 | 0.060 |
Why?
|
| Hyperhomocysteinemia | 1 | 2005 | 118 | 0.060 |
Why?
|
| Clinical Trials as Topic | 4 | 2008 | 8055 | 0.060 |
Why?
|
| Chromosomes, Human | 1 | 2006 | 442 | 0.060 |
Why?
|
| Free Radicals | 2 | 1996 | 238 | 0.060 |
Why?
|
| Nervous System | 1 | 2008 | 543 | 0.060 |
Why?
|
| Anticonvulsants | 2 | 2006 | 1879 | 0.060 |
Why?
|
| Homeostasis | 2 | 2013 | 3304 | 0.060 |
Why?
|
| Vocabulary | 1 | 2005 | 165 | 0.060 |
Why?
|
| Mice, Mutant Strains | 1 | 2007 | 1760 | 0.060 |
Why?
|
| Immunoblotting | 2 | 1999 | 1649 | 0.060 |
Why?
|
| Basal Ganglia Diseases | 1 | 2004 | 144 | 0.060 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2005 | 275 | 0.060 |
Why?
|
| Animals, Newborn | 2 | 2002 | 2675 | 0.060 |
Why?
|
| Postmortem Changes | 1 | 2004 | 119 | 0.060 |
Why?
|
| Time Factors | 4 | 2013 | 40109 | 0.060 |
Why?
|
| Membrane Potentials | 1 | 2007 | 1095 | 0.060 |
Why?
|
| Age Factors | 3 | 2020 | 18394 | 0.050 |
Why?
|
| Frontal Lobe | 2 | 2014 | 1422 | 0.050 |
Why?
|
| Genes, Reporter | 1 | 2007 | 1532 | 0.050 |
Why?
|
| Blotting, Southern | 1 | 2003 | 779 | 0.050 |
Why?
|
| Internet | 5 | 2012 | 3073 | 0.050 |
Why?
|
| Necrosis | 2 | 1999 | 1613 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2011 | 3774 | 0.050 |
Why?
|
| Play and Playthings | 1 | 2003 | 83 | 0.050 |
Why?
|
| Piperazines | 1 | 1993 | 2517 | 0.050 |
Why?
|
| Radioligand Assay | 1 | 2003 | 366 | 0.050 |
Why?
|
| Diet | 2 | 2004 | 8002 | 0.050 |
Why?
|
| Quinolinic Acid | 2 | 1999 | 67 | 0.050 |
Why?
|
| Serotonin Antagonists | 1 | 2003 | 144 | 0.050 |
Why?
|
| Safety Management | 1 | 2008 | 760 | 0.050 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2005 | 582 | 0.050 |
Why?
|
| Semantics | 1 | 2006 | 599 | 0.050 |
Why?
|
| Second Messenger Systems | 1 | 2003 | 202 | 0.050 |
Why?
|
| Indoles | 1 | 2010 | 1828 | 0.050 |
Why?
|
| Adolescent Psychiatry | 1 | 2003 | 157 | 0.050 |
Why?
|
| Drug Interactions | 1 | 2007 | 1424 | 0.050 |
Why?
|
| Plasmids | 1 | 2007 | 2277 | 0.050 |
Why?
|
| Telephone | 2 | 1995 | 622 | 0.050 |
Why?
|
| Interpersonal Relations | 1 | 2009 | 1429 | 0.050 |
Why?
|
| Anesthetics, Local | 1 | 2008 | 1001 | 0.050 |
Why?
|
| Thalamus | 2 | 2001 | 1041 | 0.050 |
Why?
|
| Calcium | 3 | 2017 | 5721 | 0.050 |
Why?
|
| Leisure Activities | 1 | 2003 | 305 | 0.050 |
Why?
|
| Electroconvulsive Therapy | 2 | 2006 | 500 | 0.050 |
Why?
|
| Protein Biosynthesis | 1 | 2009 | 2118 | 0.050 |
Why?
|
| Vitamin B 12 | 1 | 2004 | 522 | 0.050 |
Why?
|
| Lithium Carbonate | 1 | 2002 | 179 | 0.050 |
Why?
|
| Glucose | 1 | 2013 | 4361 | 0.050 |
Why?
|
| Depression | 2 | 1998 | 8026 | 0.050 |
Why?
|
| Genetic Linkage | 1 | 2006 | 2381 | 0.050 |
Why?
|
| HeLa Cells | 1 | 2007 | 3107 | 0.050 |
Why?
|
| Child Psychiatry | 1 | 2003 | 226 | 0.050 |
Why?
|
| Spider Venoms | 1 | 2000 | 43 | 0.050 |
Why?
|
| Case-Control Studies | 5 | 2017 | 21988 | 0.050 |
Why?
|
| Hematinics | 1 | 2003 | 281 | 0.050 |
Why?
|
| Gene Targeting | 1 | 2004 | 839 | 0.050 |
Why?
|
| Culture Media, Serum-Free | 1 | 2000 | 151 | 0.050 |
Why?
|
| Enzyme Inhibitors | 2 | 2003 | 3724 | 0.040 |
Why?
|
| Psychomotor Performance | 1 | 2008 | 1876 | 0.040 |
Why?
|
| Music | 1 | 2003 | 245 | 0.040 |
Why?
|
| Structure-Activity Relationship | 2 | 2012 | 3087 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2009 | 3732 | 0.040 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2000 | 203 | 0.040 |
Why?
|
| Aged | 10 | 2018 | 168617 | 0.040 |
Why?
|
| Adaptation, Ocular | 1 | 2020 | 89 | 0.040 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2020 | 109 | 0.040 |
Why?
|
| Ambulatory Care | 2 | 2004 | 2775 | 0.040 |
Why?
|
| Speech | 1 | 2005 | 547 | 0.040 |
Why?
|
| Electrophoresis, Agar Gel | 2 | 1996 | 217 | 0.040 |
Why?
|
| Ryanodine | 1 | 1999 | 46 | 0.040 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 1 | 1999 | 100 | 0.040 |
Why?
|
| Reading | 1 | 2003 | 530 | 0.040 |
Why?
|
| Cell Line | 3 | 2019 | 15636 | 0.040 |
Why?
|
| Risperidone | 1 | 2002 | 378 | 0.040 |
Why?
|
| Thapsigargin | 1 | 1999 | 102 | 0.040 |
Why?
|
| Schizophrenia, Paranoid | 1 | 1999 | 102 | 0.040 |
Why?
|
| Cell Nucleus | 3 | 1996 | 2911 | 0.040 |
Why?
|
| Social Adjustment | 1 | 2002 | 632 | 0.040 |
Why?
|
| Literature, Modern | 1 | 1999 | 30 | 0.040 |
Why?
|
| Pepstatins | 1 | 1998 | 10 | 0.040 |
Why?
|
| Adolescent | 6 | 2019 | 87560 | 0.040 |
Why?
|
| Up-Regulation | 2 | 1998 | 4132 | 0.040 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 1999 | 189 | 0.040 |
Why?
|
| Retina | 1 | 2009 | 2634 | 0.040 |
Why?
|
| Isocoumarins | 1 | 1998 | 21 | 0.040 |
Why?
|
| Phenanthrolines | 1 | 1998 | 51 | 0.040 |
Why?
|
| Cell Membrane Permeability | 1 | 2000 | 575 | 0.040 |
Why?
|
| Sucrose | 1 | 1999 | 156 | 0.040 |
Why?
|
| In Situ Hybridization | 2 | 2004 | 1900 | 0.040 |
Why?
|
| Cattle | 1 | 2024 | 3844 | 0.040 |
Why?
|
| Antibodies | 1 | 2007 | 2423 | 0.040 |
Why?
|
| Electric Conductivity | 1 | 1999 | 406 | 0.040 |
Why?
|
| Environmental Pollutants | 1 | 2008 | 1251 | 0.040 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 1999 | 214 | 0.040 |
Why?
|
| Anesthetics | 1 | 2004 | 522 | 0.040 |
Why?
|
| Cobalt | 1 | 1998 | 155 | 0.040 |
Why?
|
| Pregnancy | 2 | 2013 | 29658 | 0.040 |
Why?
|
| Ploidies | 1 | 1998 | 275 | 0.040 |
Why?
|
| Electroretinography | 1 | 2020 | 518 | 0.040 |
Why?
|
| Telemedicine | 1 | 1995 | 2998 | 0.040 |
Why?
|
| Coumarins | 1 | 1998 | 119 | 0.040 |
Why?
|
| Alcohol Withdrawal Delirium | 1 | 1998 | 27 | 0.040 |
Why?
|
| Edetic Acid | 1 | 1998 | 281 | 0.040 |
Why?
|
| Prenatal Care | 1 | 2005 | 1126 | 0.040 |
Why?
|
| Genetic Vectors | 1 | 2007 | 3377 | 0.040 |
Why?
|
| Precipitin Tests | 1 | 1998 | 815 | 0.040 |
Why?
|
| Antigen-Antibody Reactions | 1 | 1997 | 346 | 0.040 |
Why?
|
| Genotype | 1 | 2012 | 12940 | 0.040 |
Why?
|
| Action Potentials | 1 | 2005 | 1810 | 0.040 |
Why?
|
| Depressive Disorder | 2 | 2003 | 3728 | 0.040 |
Why?
|
| RNA | 1 | 2007 | 2723 | 0.040 |
Why?
|
| Perception | 1 | 2004 | 1189 | 0.040 |
Why?
|
| Anisomycin | 1 | 1996 | 27 | 0.040 |
Why?
|
| Aurintricarboxylic Acid | 1 | 1996 | 10 | 0.040 |
Why?
|
| Hydrolysis | 1 | 1998 | 665 | 0.040 |
Why?
|
| Antiviral Agents | 2 | 2024 | 3060 | 0.040 |
Why?
|
| Risk Factors | 4 | 2020 | 74167 | 0.040 |
Why?
|
| Tyrosine 3-Monooxygenase | 2 | 1995 | 370 | 0.040 |
Why?
|
| Ganglia, Spinal | 1 | 1999 | 523 | 0.040 |
Why?
|
| Central Nervous System Depressants | 1 | 1998 | 164 | 0.030 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 1998 | 179 | 0.030 |
Why?
|
| Nerve Growth Factors | 1 | 2000 | 562 | 0.030 |
Why?
|
| Encephalitis | 1 | 2020 | 435 | 0.030 |
Why?
|
| Binding, Competitive | 1 | 1998 | 1143 | 0.030 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2001 | 859 | 0.030 |
Why?
|
| Leucine | 1 | 1998 | 548 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2020 | 1335 | 0.030 |
Why?
|
| Photoreceptor Cells | 1 | 1997 | 236 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2018 | 41247 | 0.030 |
Why?
|
| Prostatic Neoplasms | 2 | 1998 | 11324 | 0.030 |
Why?
|
| Dactinomycin | 1 | 1996 | 303 | 0.030 |
Why?
|
| Gliosis | 1 | 2017 | 244 | 0.030 |
Why?
|
| Neurodegenerative Diseases | 1 | 2005 | 1080 | 0.030 |
Why?
|
| Cycloheximide | 1 | 1996 | 343 | 0.030 |
Why?
|
| Receptors, Serotonin | 1 | 1977 | 205 | 0.030 |
Why?
|
| United States | 7 | 2012 | 72237 | 0.030 |
Why?
|
| Brain Ischemia | 1 | 2010 | 3128 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 2 | 1998 | 4716 | 0.030 |
Why?
|
| Glutathione | 1 | 1998 | 582 | 0.030 |
Why?
|
| Multicenter Studies as Topic | 1 | 2001 | 1719 | 0.030 |
Why?
|
| Brain Waves | 1 | 2020 | 400 | 0.030 |
Why?
|
| Psychoses, Alcoholic | 1 | 1995 | 1 | 0.030 |
Why?
|
| Caudate Nucleus | 1 | 1977 | 389 | 0.030 |
Why?
|
| Antibody Specificity | 1 | 1997 | 1061 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2011 | 9374 | 0.030 |
Why?
|
| Young Adult | 6 | 2020 | 58483 | 0.030 |
Why?
|
| Risk | 2 | 2008 | 9623 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2003 | 10333 | 0.030 |
Why?
|
| Pyrrolidines | 1 | 1977 | 336 | 0.030 |
Why?
|
| Choline O-Acetyltransferase | 1 | 1995 | 155 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2019 | 1755 | 0.030 |
Why?
|
| Phrenic Nerve | 1 | 1995 | 79 | 0.030 |
Why?
|
| Organ Specificity | 1 | 1999 | 1953 | 0.030 |
Why?
|
| Statistics as Topic | 2 | 2015 | 2364 | 0.030 |
Why?
|
| Intestines | 1 | 2003 | 1905 | 0.030 |
Why?
|
| Random Allocation | 1 | 2019 | 2393 | 0.030 |
Why?
|
| Zinc | 1 | 1999 | 688 | 0.030 |
Why?
|
| Protease Inhibitors | 1 | 1998 | 755 | 0.030 |
Why?
|
| Radioimmunoassay | 1 | 1995 | 866 | 0.030 |
Why?
|
| Binding Sites | 2 | 2004 | 6053 | 0.030 |
Why?
|
| Methionine | 1 | 1996 | 569 | 0.030 |
Why?
|
| Arachidonic Acid | 1 | 1996 | 434 | 0.030 |
Why?
|
| Forensic Anthropology | 1 | 2013 | 8 | 0.030 |
Why?
|
| Substrate Specificity | 1 | 1998 | 1792 | 0.030 |
Why?
|
| Norepinephrine | 2 | 1993 | 899 | 0.030 |
Why?
|
| Diencephalon | 1 | 1993 | 54 | 0.030 |
Why?
|
| Neuroprotective Agents | 1 | 2000 | 960 | 0.030 |
Why?
|
| Molecular Probes | 1 | 1995 | 312 | 0.030 |
Why?
|
| Fluorescent Dyes | 1 | 2002 | 1914 | 0.030 |
Why?
|
| Ireland | 1 | 2013 | 171 | 0.030 |
Why?
|
| Vertebrates | 1 | 1995 | 227 | 0.030 |
Why?
|
| Oligopeptides | 1 | 1999 | 1187 | 0.030 |
Why?
|
| Gliotoxin | 1 | 2013 | 3 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2020 | 1512 | 0.030 |
Why?
|
| Ion Channels | 1 | 1998 | 1043 | 0.030 |
Why?
|
| Iron | 1 | 2002 | 1785 | 0.030 |
Why?
|
| Guinea Pigs | 1 | 1995 | 1314 | 0.030 |
Why?
|
| CpG Islands | 1 | 2018 | 1221 | 0.030 |
Why?
|
| Cell Count | 1 | 1997 | 1837 | 0.030 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 1995 | 550 | 0.030 |
Why?
|
| Gene Library | 1 | 1996 | 1060 | 0.030 |
Why?
|
| Benzodiazepines | 1 | 1999 | 1131 | 0.030 |
Why?
|
| Age Distribution | 1 | 2019 | 2892 | 0.030 |
Why?
|
| Telencephalon | 1 | 1993 | 142 | 0.030 |
Why?
|
| Dextroamphetamine | 1 | 1973 | 134 | 0.030 |
Why?
|
| Environmental Exposure | 1 | 2008 | 4389 | 0.030 |
Why?
|
| Epiphyses | 1 | 2013 | 190 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2022 | 17750 | 0.030 |
Why?
|
| Nitroarginine | 1 | 1992 | 66 | 0.030 |
Why?
|
| DNA | 2 | 1996 | 7237 | 0.030 |
Why?
|
| Severity of Illness Index | 2 | 2004 | 15815 | 0.030 |
Why?
|
| Television | 1 | 1995 | 409 | 0.030 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1993 | 412 | 0.030 |
Why?
|
| Diagnostic Imaging | 1 | 2006 | 3526 | 0.030 |
Why?
|
| Brain Stem | 1 | 1997 | 856 | 0.030 |
Why?
|
| Isoenzymes | 1 | 1997 | 1690 | 0.030 |
Why?
|
| Azo Compounds | 1 | 1992 | 117 | 0.020 |
Why?
|
| Endopeptidases | 1 | 1996 | 772 | 0.020 |
Why?
|
| Avoidance Learning | 1 | 1973 | 248 | 0.020 |
Why?
|
| Fibula | 1 | 2013 | 265 | 0.020 |
Why?
|
| Cyclic GMP | 1 | 1992 | 395 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2000 | 2866 | 0.020 |
Why?
|
| Adrenal Glands | 1 | 1973 | 556 | 0.020 |
Why?
|
| Pyrroles | 1 | 1977 | 1135 | 0.020 |
Why?
|
| Forecasting | 1 | 2000 | 2931 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1995 | 2474 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 1998 | 6131 | 0.020 |
Why?
|
| Psychotherapy | 1 | 1999 | 1638 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2014 | 12268 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2019 | 2012 | 0.020 |
Why?
|
| Nitro Compounds | 1 | 2010 | 74 | 0.020 |
Why?
|
| Isomerism | 1 | 2010 | 197 | 0.020 |
Why?
|
| Hydrogen Peroxide | 1 | 1993 | 733 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 1996 | 3604 | 0.020 |
Why?
|
| Genome | 1 | 2018 | 1739 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 1996 | 2225 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2010 | 174 | 0.020 |
Why?
|
| Aged, 80 and over | 4 | 2018 | 58867 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 1998 | 6070 | 0.020 |
Why?
|
| Neostriatum | 2 | 2000 | 246 | 0.020 |
Why?
|
| Mental Disorders | 2 | 2000 | 6788 | 0.020 |
Why?
|
| Dogs | 1 | 1993 | 3838 | 0.020 |
Why?
|
| Magnesium | 1 | 1992 | 810 | 0.020 |
Why?
|
| Arginine | 1 | 1992 | 934 | 0.020 |
Why?
|
| Depressive Disorder, Major | 1 | 2006 | 4732 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 1992 | 1849 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2003 | 12964 | 0.020 |
Why?
|
| Kidney | 1 | 2003 | 7066 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 1998 | 6542 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2012 | 1895 | 0.020 |
Why?
|
| Tibia | 1 | 2013 | 1062 | 0.020 |
Why?
|
| Brain Infarction | 1 | 2010 | 292 | 0.020 |
Why?
|
| Femur | 1 | 2013 | 1300 | 0.020 |
Why?
|
| Insulin-Secreting Cells | 1 | 2014 | 903 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2019 | 3556 | 0.020 |
Why?
|
| Stem Cells | 1 | 2000 | 3525 | 0.020 |
Why?
|
| Exercise | 1 | 2003 | 5773 | 0.020 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2010 | 486 | 0.020 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 1992 | 1109 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 1998 | 13456 | 0.020 |
Why?
|
| DNA Damage | 1 | 1996 | 2442 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 1999 | 64879 | 0.020 |
Why?
|
| Insulin | 1 | 2000 | 6591 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 1999 | 7003 | 0.020 |
Why?
|
| Light | 1 | 2011 | 1343 | 0.020 |
Why?
|
| Electroencephalography | 1 | 2021 | 6174 | 0.020 |
Why?
|
| Ligands | 1 | 2012 | 3275 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 1998 | 4939 | 0.020 |
Why?
|
| Metabolomics | 1 | 2014 | 1620 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 1993 | 1902 | 0.020 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 1996 | 1457 | 0.020 |
Why?
|
| Seizures | 1 | 1998 | 2908 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2018 | 3754 | 0.010 |
Why?
|
| Anxiety Disorders | 1 | 1995 | 2709 | 0.010 |
Why?
|
| Chlorpromazine | 1 | 2004 | 111 | 0.010 |
Why?
|
| Disease Progression | 1 | 2001 | 13479 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2018 | 4371 | 0.010 |
Why?
|
| Proteomics | 1 | 2017 | 3804 | 0.010 |
Why?
|
| Verbal Behavior | 1 | 2005 | 335 | 0.010 |
Why?
|
| Linear Models | 1 | 2013 | 5876 | 0.010 |
Why?
|
| Neural Conduction | 1 | 2005 | 441 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 1992 | 4625 | 0.010 |
Why?
|
| Haplorhini | 1 | 2004 | 529 | 0.010 |
Why?
|
| Autoradiography | 1 | 2004 | 730 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2012 | 5427 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2010 | 2667 | 0.010 |
Why?
|
| Pilot Projects | 1 | 1995 | 8540 | 0.010 |
Why?
|
| Alcohol Drinking | 1 | 1995 | 4006 | 0.010 |
Why?
|
| Models, Animal | 1 | 2008 | 2118 | 0.010 |
Why?
|
| Prevalence | 1 | 2019 | 15641 | 0.010 |
Why?
|
| Electrophysiology | 1 | 2005 | 1265 | 0.010 |
Why?
|
| Parkinson Disease | 1 | 1996 | 2843 | 0.010 |
Why?
|
| Epilepsy | 1 | 1997 | 3260 | 0.010 |
Why?
|
| Child | 2 | 2013 | 79623 | 0.010 |
Why?
|
| Sympathectomy, Chemical | 1 | 2000 | 25 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2017 | 8929 | 0.010 |
Why?
|
| Incidence | 1 | 2019 | 21336 | 0.010 |
Why?
|
| Sympatholytics | 1 | 2000 | 82 | 0.010 |
Why?
|
| Apomorphine | 1 | 2000 | 149 | 0.010 |
Why?
|
| Genes, fos | 1 | 2000 | 174 | 0.010 |
Why?
|
| Drug Resistance | 1 | 2006 | 1611 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2002 | 39216 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2014 | 6368 | 0.010 |
Why?
|
| Oxidopamine | 1 | 2000 | 172 | 0.010 |
Why?
|
| Stereotyped Behavior | 1 | 2000 | 135 | 0.010 |
Why?
|
| Mass Screening | 1 | 1995 | 5419 | 0.010 |
Why?
|
| Internship and Residency | 1 | 1999 | 5861 | 0.010 |
Why?
|
| Cell Separation | 1 | 2005 | 1724 | 0.010 |
Why?
|
| Bicuculline | 1 | 1998 | 96 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2004 | 2509 | 0.010 |
Why?
|
| Rotation | 1 | 2000 | 514 | 0.010 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2005 | 1987 | 0.010 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2000 | 485 | 0.010 |
Why?
|
| Dopamine Agonists | 1 | 2000 | 352 | 0.010 |
Why?
|
| Lysergic Acid Diethylamide | 1 | 1977 | 47 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 1995 | 20031 | 0.010 |
Why?
|
| Tomography, Emission-Computed | 1 | 2000 | 1121 | 0.010 |
Why?
|
| Radiochemistry | 1 | 1996 | 49 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1998 | 20461 | 0.010 |
Why?
|
| Injections | 1 | 1997 | 832 | 0.010 |
Why?
|
| Dopamine beta-Hydroxylase | 1 | 1973 | 74 | 0.010 |
Why?
|
| Pyrrolidinones | 1 | 1993 | 116 | 0.010 |
Why?
|
| Tritium | 1 | 1973 | 707 | 0.010 |
Why?
|
| Rats, Inbred Strains | 1 | 1973 | 2094 | 0.010 |
Why?
|
| Methyltransferases | 1 | 1973 | 377 | 0.010 |
Why?
|
| Cerebrovascular Circulation | 1 | 2000 | 2725 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2000 | 4164 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2000 | 8313 | 0.010 |
Why?
|
| Species Specificity | 1 | 1973 | 2412 | 0.010 |
Why?
|
| Tyrosine | 1 | 1973 | 1440 | 0.010 |
Why?
|
| Data Collection | 1 | 1995 | 3317 | 0.000 |
Why?
|
| Cross-Sectional Studies | 1 | 1995 | 25860 | 0.000 |
Why?
|